Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity
Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity
复制标题
还原型烟酰胺腺嘌呤二核苷酸磷酸抑制 MPTP 诱导的神经炎症和神经毒性
DOI:
10.1016/j.neuroscience.2018.08.032
复制
发表时间:
2018-11
期刊:
影响因子:
3.3
通讯作者:
Qin Zheng-Hong
中科院分区:
文献类型:
--
作者:
Zhou Ying;Wu Junchao;Sheng Rui;Li Mei;Wang Yan;Han Rong;Han Feng;Chen Zhong;Qin Zheng-Hong
It is generally believed that oxidative stress and neuroinflammation are implicated in the pathogenesis of Parkinson’s disease (PD). Reduced nicotinamide adenine dinucleotide phosphate (NADPH) has been demonstrated to have potent neuroprotective effects against oxidative stress. In the present research, we investigated if NADPH could offer neuroprotection by inhibiting glia-mediated neuroinflammation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mechanism contributing to PD pathogenesis. The current data demonstrated that MPTP/MPP+increased levels of reactive oxygen species (ROS), activated glial cells, and inflammasome proteins in the substantia nigra (SNpc), in addition to inducing the nuclear translocation of nuclear factor-κB (NF-κB) and phosphorylation of p38 MAPK. These responses were inhibited by supplementation of exogenous NADPH. Moreover, NADPH effectively decreased MPP+-induced excessive production of ROS, p38 phosphorylation and inflammatory protein of Cyclooxygenase2 (COX2) in cultured microglial BV-2 cells in vitro studies. Similarly, the p38 MAPK inhibitor SB203580 suppressed the upregulation of MPP+-induced p38 phosphorylation and COX2 protein levels. Co-culture of neuronal cells with MPP+-primed BV-2 cells increased the levels of tumor necrosis factor-alpha (TNF-α) and induced cell death of neuronal cells. These effects were diminished by TNF-α neutralizing antibody and NADPH. NADPH reduced motor dysfunction and the loss of dopaminergic (DA) cells induced by MPTP. Therefore, the present study demonstrates that NADPH protects DA neurons by inhibiting oxidative stress and glia-mediated neuroinflammation both in vitro and in vivo, thus suggesting a potential of clinical application for PD and other neurodegenerative diseases.
登录
查看更多内容
DOI:
10.1201/b12952-20
发表时间:
2021-04
期刊:
The Lancet
影响因子:
--
作者:
B. Bloem;M. Okun;C. Klein
通讯作者:
B. Bloem;M. Okun;C. Klein
影响因子:
7.4
作者:
Smeyne, Michelle;Smeyne, Richard Jay
通讯作者:
Smeyne, Richard Jay
影响因子:
5.2
作者:
Figueiredo-Pereira ME;Corwin C;Babich J
通讯作者:
Babich J
影响因子:
4.8
作者:
Rai SN;Birla H;Singh SS;Zahra W;Patil RR;Jadhav JP;Gedda MR;Singh SP
通讯作者:
Singh SP
影响因子:
15.1
作者:
Zhou Y;Lu M;Du RH;Qiao C;Jiang CY;Zhang KZ;Ding JH;Hu G
通讯作者:
Hu G